Yuval Shaked

Yuval Shaked, Ph.D., serves as a Principal Investigator and Professor at Technion - Israel Institute of Technology since August 2008, focusing on enhancing the efficacy of conventional cancer therapies. With experience as a Co-Founder and Chief Scientific Advisor for OncoHost and REMEDY CELL Ltd. since 2017 and 2020 respectively, Yuval Shaked contributes to advancements in cancer treatment strategies. Previously, Yuval Shaked was a Postdoctoral Fellow at Sunnybrook Health Sciences Centre from September 2002 to July 2008, conducting research on circulating endothelial cells as potential biomarkers for antiangiogenic drug dosing. Yuval Shaked completed a Doctor of Philosophy in Pre-Medicine/Pre-Medical Studies at The Hebrew University of Jerusalem from October 1997 to September 2002, following earlier education at Katzenelson High School in Kfar Saba, Israel.